Breiter Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Breiter Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$311K	Hold	2,385	–	–	0.15%	111
2021 Q4	$364K	Hold	2,385	–	–	0.18%	102
2021 Q3	$386K	Hold	2,385	–	–	0.22%	99
2021 Q2	$390K	Buy	+2,385	New	+$367K	0.21%	100
2021 Q1	–	Sell	-2,805	Closed	-$425K	–	78
2020 Q4	$425K	Sell	2,805 -119	-4%	-$17K	0.3%	82
2020 Q3	$396K	Hold	2,924	–	–	0.32%	76
2020 Q2	$400K	Hold	2,924	–	–	0.37%	71
2020 Q1	$315K	Buy	+2,924	New	+$337K	0.37%	73

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Breiter Capital Management's IBB Position: Q1 2022 in Review

Breiter Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2022 at 2,385 shares worth $311K. The position accounts for 0.15% of the portfolio, ranked #111.

Breiter Capital Management first reported a position in IBB in Q1 2020 and has held it in 8 quarters since. The position peaked at $425K in Q4 2020. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Breiter Capital Management held 2,385 shares of iShares Biotechnology ETF worth $311K as of Q1 2022.
Breiter Capital Management left its iShares Biotechnology ETF share count unchanged in Q1 2022.
iShares Biotechnology ETF made up 0.15% of Breiter Capital Management's portfolio in Q1 2022, its #111 holding.
Breiter Capital Management first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 8 quarters since.
Breiter Capital Management's iShares Biotechnology ETF position peaked at $425K in Q4 2020.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Breiter Capital Management's 13F filing for Q1 2022, filed 11 May 2022.